Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 8 per cent to Rs 57 crore for the fourth quarter ended March 31, 2023.

The company had reported a net profit of Rs 62 crore in the January-March quarter a year ago.

Revenue from operations rose to Rs 491 crore for the fourth quarter as compared with Rs 485 crore in the year-ago period, Dr Lal PathLabs said in a regulatory filing.

For the year ended March 31, 2023, the company reported a consolidated net profit of Rs 241 crore as against Rs 350 crore in FY22.

Also read: Dr Reddy’s Labs share price outlook: Weak Revlimid sales to hurt as pharma grows; Check brokerage calls, target

The company said its board has recommended a final dividend of Rs 6 per share (60 per cent) on a face value of Rs 10 per share for the year ended March 31, 2023.

Shares of the company ended 2.21 per cent down at Rs 1,906.80 apiece on the BSE.

Read Next
ONGC reports 28% jump in consolidated net profit in Q2FY26
KPIT Tech Q2 profit falls 17% at Rs 169 cr 
KPIT Tech Q2 net profit down 17%, revenue up 7.9% YoY